Risky ‘gain-of-function’ studies need stricter guidance, say US researchers
Nature, 2022, pp. d41586—022—01209—w
Abstract
After a delay caused by the COVID-19 pandemic, US biosecurity board revisits policies governing risky pathogen experiments.
Nature, 2022, pp. d41586—022—01209—w
After a delay caused by the COVID-19 pandemic, US biosecurity board revisits policies governing risky pathogen experiments.